LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)-30-MONTH DATA FROM THE RELIANCE REGISTRY

被引：0

作者：

Kuemmerle-Deschner, J. B. ^{[1
]}

Kortus-Goetze, B. ^{[2
]}

Oommen, P. ^{[3
]}

Janda, A. ^{[4
]}

Rech, J. ^{[5
,6
]}

Kallinich, T. ^{[7
]}

Weller-Heinemann, F. ^{[8
]}

Horneff, G. ^{[9
]}

Foeldvari, I. ^{[10
]}

Schuetz, C. ^{[11
]}

Borte, M. ^{[12
]}

Braner, A. ^{[13
]}

Weber-Arden, J. ^{[14
]}

Blank, N. ^{[15
]}

机构：

[1] Univ Hosp Tuebingen, Div Pediat Rheumatol, Dept Pediat, Tubingen, Germany

[2] Univ Marburg, Div Nephrol, Marburg, Germany

[3] Heinrich Heine Univ Dusseldorf, Clin Pediat Hematol Oncol & Clin Immunol, Dusseldorf, Germany

[4] Univ Hosp Ulm, Dept Pediat, Ulm, Germany

[5] Friedrich Alexander Univ FAU, Erlangen, Germany

[6] Erlangen Nurnberg & Univ Erlangen, Dept Internal Med 3, Rheumatol & Immunol, Erlangen, Germany

[7] Charite Univ Med Berlin, Dept Pediat, Div Pulmonol Immunol & Crit Care Med, Berlin, Germany

[8] Klinikum Bremen Mitte, Hess Kinderklin, Bremen, Germany

[9] Asklepios Clin Sankt Augustin, St Augustin, Germany

[10] Ctr Pediat & Adolescence Rheumatol, Hamburg, Germany

[11] Tech Univ Dresden, Pediat, Med Fak Carl Gustav Carus, Dresden, Germany

[12] Hosp St Georg GmbH Leipzig, Immuno Deficiency Ctr Leipzig IDCL, Leipzig, Germany

[13] Univ Hosp Frankfurt, Dept Med 2, Rheumatol, Frankfurt, Germany

[14] Novartis Pharma GmbH, Nurnberg, Germany

[15] Univ Heidelberg Hosp, Rheumatol, Heidelberg, Germany

来源：

关键词：

D O I：

10.1136/annrheumdis-2021-eular.3716

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OP0092

引用

页码：50 / 51

页数：2